Upcoming
Join Viz.ai at booth 3821
Las Vegas, NV
Venetian Resort Las Vegas, NV
November 16 - November 18, 2026
.
By submitting this form, you agree that Viz.ai may use your information as described in our Privacy Policy, including to schedule meetings and share information about our products and services, in accordance with our Privacy Policy.
Meet Viz.ai at HLTH 2026 to see how Viz.ai One helps standardize care coordination across the enterprise, reduce transfer leakage, and move more patients to treatment faster. Used by 2,000+ hospitals and health systems, backed by 125+ peer-reviewed publications and 50+ FDA-cleared solutions, and trusted by 14 life science companies.
Ranked #1 in AI clinical decision support by Black Book, two years running.
One enterprise integration connects detection, review, activation, and measurement across every service line, inside the EHR and PACS you already run. No per-department point solutions, no new contract as the platform grows.
The results health systems are seeing with Viz.ai One
42% increase in stroke transfers treated with endovascular thrombectomy.¹ 74% reduction in in-hospital mortality risk for pulmonary embolism.² 8.4x more patients receiving guideline-directed cardiac monitoring.³ 2.5-day reduction in hospital length of stay.⁴
¹Bonner et al., Interv Neuroradiol, 2024. ²Shapiro et al., AVF 2024. ³Data on file, Viz.ai. ⁴Hassan et al., Interv Neuroradiol, 2020.
“What Viz.ai has built over ten years is infrastructure that makes the right thing easier to do than the wrong thing. That’s rare. And it’s what actually moves outcomes.” — Anthony Mazzarelli, MD, Co-President and CEO, Cooper University Health Care
Independent, user-validated findings in 2026 report reinforces Viz.ai's growing leadership over a competitive field as healthcare shifts to clinical AI...
Apr 09, 2026
HLTH Report: From pilots to sustained enterprise execution.
Mar 05, 2026
From the first stroke algorithm to the leading enterprise clinical AI platform, Viz.ai enters its second decade, backed by 125+...
Jul 28, 2026
Redefining Pharma Go-To-Market in the Era of AI-Empowered HCPs
Feb 23, 2026
